Waverly Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-31,428
| Closed | -$805K | – | 982 |
|
|
2024
Q3 | $805K | Sell |
31,428
-1,826
| -5% | -$46.7K | 0.01% | 487 |
|
|
2024
Q2 | $781K | Sell |
33,254
-562
| -2% | -$13.2K | 0.02% | 478 |
|
|
2024
Q1 | $973K | Hold |
33,816
| – | – | 0.02% | 374 |
|
|
2023
Q4 | $1.11M | Hold |
33,816
| – | – | 0.04% | 208 |
|
|
2023
Q3 | $942K | Sell |
33,816
-859
| -2% | -$23.9K | 0.04% | 204 |
|
|
2023
Q2 | $1.18M | Buy |
34,675
+4,825
| +16% | +$164K | 0.05% | 171 |
|
|
2023
Q1 | $898K | Buy |
29,850
+2,700
| +10% | +$81.2K | 0.05% | 150 |
|
|
2022
Q4 | $766K | Sell |
27,150
-791
| -3% | -$22.3K | 0.04% | 144 |
|
|
2022
Q3 | $918K | Buy |
27,941
+9,142
| +49% | +$300K | 0.06% | 116 |
|
|
2022
Q2 | $592K | Sell |
18,799
-3,760
| -17% | -$118K | 0.05% | 118 |
|
|
2022
Q1 | $1.04M | Hold |
22,559
| – | – | 0.09% | 77 |
|
|
2021
Q4 | $1.1M | Hold |
22,559
| – | – | 0.09% | 75 |
|
|
2021
Q3 | $1.66M | Buy |
22,559
+15,989
| +243% | +$1.18M | 0.14% | 57 |
|
|
2021
Q2 | $530K | Hold |
6,570
| – | – | 0.05% | 109 |
|
|
2021
Q1 | $518K | Sell |
6,570
-155
| -2% | -$12.2K | 0.05% | 100 |
|
|
2020
Q4 | $746K | Sell |
6,725
-1,375
| -17% | -$153K | 0.08% | 76 |
|
|
2020
Q3 | $532K | Hold |
8,100
| – | – | 0.07% | 83 |
|
|
2020
Q2 | $481K | Hold |
8,100
| – | – | 0.06% | 88 |
|
|
2020
Q1 | $253K | Hold |
8,100
| – | – | 0.04% | 114 |
|
|
2019
Q4 | $286K | Hold |
8,100
| – | – | 0.04% | 112 |
|
|
2019
Q3 | $239K | Hold |
8,100
| – | – | 0.03% | 116 |
|
|
2019
Q2 | $279K | Buy |
+8,100
| New | +$279K | 0.04% | 106 |
|